Roche VENTANA MMR RxDx Panel Gains EU IVDR Approval for Multiple Cancers
Roche has received European Union In Vitro Diagnostic Regulation approval for several label expansions of its VENTANA MMR…
AstraZeneca Collaborates with Roche Diagnostics Asia Pacific to Help Accelerate Sustainable Ecosystem for Advanced Pathology in Breast and Lung Cancer
SINGAPORE, May 18, 2026 /PRNewswire/ — AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of…
Roche’s Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer’s-related amyloid pathology
Rules out Alzheimer’s pathology in early stages to enhance diagnostic pathway efficiency Provides new opportunity to broaden access…